Linagliptin as a Multi-Target Neuroprotective Agent in Cognitive Disorders: Molecular Mechanisms and Translational Challenges—A Narrative Review
Drug Design, Development and Therapy · 2026-11 · Volume 20 · 1-13
DOI: 10.2147/dddt.s645071 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-11. Verfasst von Leila Mohammadi und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Mohammadi, L., Roghani, M., & Baluchnejadmojarad, T. (2026). Linagliptin as a Multi-Target Neuroprotective Agent in Cognitive Disorders: Molecular Mechanisms and Translational Challenges—A Narrative Review. Drug Design, Development and Therapy, Volume 20, 1-13. https://doi.org/10.2147/dddt.s645071
Vancouver
Mohammadi L, Roghani M, Baluchnejadmojarad T. Linagliptin as a Multi-Target Neuroprotective Agent in Cognitive Disorders: Molecular Mechanisms and Translational Challenges—A Narrative Review. Drug Design, Development and Therapy. 2026;Volume 20:1-13. doi:10.2147/dddt.s645071
BibTeX
@article{Mohammadi2026,
author = {Mohammadi, Leila and Roghani, Mehrdad and Baluchnejadmojarad, Tourandokht},
title = {Linagliptin as a Multi-Target Neuroprotective Agent in Cognitive Disorders: Molecular Mechanisms and Translational Challenges—A Narrative Review},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--13},
doi = {10.2147/dddt.s645071}
}
EUVIMED